TY - JOUR
T1 - Methodologies for Assessing the Acceptability of Oral Formulations among children and older adults: A Systematic Review
AU - Ranmal, Sejal
AU - O’Brien, Fiona
AU - Lopez, Felipe
AU - Ruiz, Fabrice
AU - Orlu, Mine
AU - Tuleu, Catherine
AU - Walsh, Jennifer
AU - Liu, Fang
N1 - This is an open access article distributed under the terms and conditions of the Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Acceptability of medicinal products in children and older populations is pivotal in ensuring adherence and therapeutic outcomes. This review systematically identifies studies reporting on formulation aspects of oral medications that affect their acceptability in these patient groups. Particular emphasis is placed on the evaluation of the methodologies employed in the studies. Sixty-eight studies were included for analysis, with 51 (75%) in children and 17 (25%) in older populations. The studies evaluated a range of oral formulations; however, the methodologies used differ considerably in participants’ characteristics, study settings, tools, acceptability definitions and criteria. It is evident that there is a lack of standardisation in study design as well as the assessment methods used in assessing acceptability of medicines in children and older populations. This review presents a systematic analysis on methods employed for assessing acceptability of oral medicines in children and older adults, to provide insights and recommendations regarding the design of reliable instruments in future studies.
AB - Acceptability of medicinal products in children and older populations is pivotal in ensuring adherence and therapeutic outcomes. This review systematically identifies studies reporting on formulation aspects of oral medications that affect their acceptability in these patient groups. Particular emphasis is placed on the evaluation of the methodologies employed in the studies. Sixty-eight studies were included for analysis, with 51 (75%) in children and 17 (25%) in older populations. The studies evaluated a range of oral formulations; however, the methodologies used differ considerably in participants’ characteristics, study settings, tools, acceptability definitions and criteria. It is evident that there is a lack of standardisation in study design as well as the assessment methods used in assessing acceptability of medicines in children and older populations. This review presents a systematic analysis on methods employed for assessing acceptability of oral medicines in children and older adults, to provide insights and recommendations regarding the design of reliable instruments in future studies.
UR - http://www.scopus.com/inward/record.url?scp=85042196828&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2018.01.038
DO - 10.1016/j.drudis.2018.01.038
M3 - Review article
SN - 1359-6446
VL - 23
SP - 830
EP - 847
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 4
ER -